Results 251 to 260 of about 60,915 (280)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon

Frontiers in Immunology, 2022
Xinyue Chen, Zhenhuan Cao, Chen Xinyue   +2 more
exaly  

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo , hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection

Emerging Microbes and Infections, 2020
Romina Salpini, Arianna Battisti, Lorenzo Piermatteo   +2 more
exaly  

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum

Journal of Clinical Virology, 2011
Karsten Wursthorn, Jerzy Jaroszewicz, Ingmar Mederacke   +2 more
exaly  

Subtype of HBsAg in Chile

Vox Sanguinis, 1982
openaire   +2 more sources

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective

Journal of Hepatology, 2010
Jerzy Jaroszewicz, Karsten Wursthorn, Katja Deterding   +2 more
exaly  

Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants

Medical Microbiology and Immunology, 2007
P Burgisser, S Louisirirotchanakul, Weber B   +2 more
exaly  

HBsAg

2009
openaire   +1 more source

The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays

Journal of Clinical Virology, 2012
Jens Verheyen, Maria Neumann-Fraune, Thomas Berg   +2 more
exaly  

Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a

Virologica Sinica, 2020
Minghui Li, Lu Zhang, Yao Lu
exaly  

LIVER DISEASE IN HBsAg CARRIERS

The Lancet, 1982
T, Fernández-de-Sevilla, J M, Martínez-Vázquez, I, Ocaña, A, Ruibal, R, Bacardi   +4 more
openaire   +2 more sources